OBI — Ondine Biomedical Share News
0.000.00%
Last trade - 00:00- £46.56m
- £41.35m
- CA$2.05m
REG - Ondine Biomedical - Seasoned MedTech Exec Appointed as CFO & COO
AnnouncementRCS - Ondine Biomedical - Nasal photodisinfection US market potential
AnnouncementREG - Ondine Biomedical - Ondine President increases shareholding
AnnouncementREG - Ondine Biomedical - Ondine CEO increases shareholding
AnnouncementREG - Ondine Biomedical - Ondine CEO increases ownership
AnnouncementREG - Ondine Biomedical - Appointment of Nominated and Financial Adviser
AnnouncementREG - Ondine Biomedical - CEO Increases Stake in Ondine
AnnouncementREG - Ondine Biomedical - Director Increases Stake in Ondine
AnnouncementREG - Ondine Biomedical - Notification of Major Holdings
AnnouncementREG - Ondine Biomedical M&G PLC - Notification of Major Holdings
AnnouncementREG - AIM - AIM Notice - 29/01/2025
AnnouncementREG - Ondine Biomedical - Grant of Options and Warrants
AnnouncementREG - Ondine Biomedical - HCA to invest US$4 million in Ondine
AnnouncementREG - Ondine Biomedical - Ondine recruits first patient for US Phase 3 trial
AnnouncementREG - Ondine Biomedical - Ondine commencing US Phase 3 clinical trial
AnnouncementREG - Ondine Biomedical M&G PLC - Notification of Major Holdings
AnnouncementREG - Ondine Biomedical - Notification of Major Holdings
AnnouncementREG - AIM - AIM Notice - 22/11/2024
AnnouncementREG - Ondine Biomedical - Director Holdings
Announcement